Bioventus Inc. Class A Common Stock (BVS) Stock Price

BVSStock

$13.30+93.31%52W

Market Cap$908.46M

P/E49.20x

PEG Ratio1.53

Div yield—

Beta0.66

BVS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)24.30%

Price vs S&P 500 (4W)1.25%

PEG Ratio1.53

VGM Score65.97

P/E Ratio (Annual)49.20x

P/CF (Annual)14.98x

Book Value / Share (Quarterly)$2.72

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)3.52%

Cash Flow / Share (Quarterly)$1.12

Price vs S&P 500 (YTD)66.84%

Gross Margin (TTM)68.65%

Net Profit Margin (TTM)9.36%

EPS (TTM)$0.78

10-Day Avg Trading Volume0.34M

EPS Excl Extra (TTM)$0.78

Revenue Growth (5Y)12.08%

EPS (Annual)$0.33

ROI (Annual)4.66%

Gross Margin (Annual)68.33%

Net Profit Margin (5Y Avg)-11.86%

Cash / Share (Quarterly)$0.35

P/E Basic Excl Extra (TTM)20.54x

Revenue Growth QoQ (YoY)3.76%

EPS Growth (5Y)2.26%

P/E Normalized (Annual)49.20x

ROA (Last FY)3.33%

Revenue Growth TTM (YoY)3.14%

EBITD / Share (TTM)$0.90

ROE (5Y Avg)-29.59%

Operating Margin (TTM)9.96%

Cash Flow / Share (Annual)$0.87

P/B Ratio4.90x

P/B Ratio (Quarterly)2.90x

Net Income / Employee (Annual)$24,400

EV / Revenue (TTM)2.31x

Net Interest Coverage (TTM)2.02x

ROA (TTM)8.04%

EPS Growth QoQ (YoY)333.92%

EV / EBITDA (TTM)21.44x

EPS Incl Extra (Annual)$0.33

Current Ratio (Annual)1.70x

Quick Ratio (Quarterly)1.10x

3-Month Avg Trading Volume0.62M

52-Week Price Return93.31%

EV / Free Cash Flow (Annual)18.67x

P/E Incl Extra (TTM)20.54x

Revenue / Employee (TTM)$625,600

Tangible BV / Share (Quarterly)$-4.10

P/S Ratio (Annual)1.97x

Asset Turnover (Annual)0.83x

52-Week High$15.89

Operating Margin (5Y Avg)-11.17%

EPS Excl Extra (Annual)$0.33

CapEx CAGR (5Y)-8.93%

26-Week Price Return34.21%

Quick Ratio (Annual)1.12x

13-Week Price Return10.28%

Total Debt / Equity (Annual)1.65x

Current Ratio (Quarterly)1.69x

Enterprise Value$1.35B

Revenue / Share Growth (5Y)7.37%

Asset Turnover (TTM)0.86x

Revenue / Employee (Annual)$610,800

Inventory Turnover (Annual)2.06x

Pretax Margin (Annual)4.53%

Cash / Share (Annual)$0.62

3-Month Return Std Dev49.10%

Gross Margin (5Y Avg)67.00%

Net Income / Employee (TTM)$58,600

EBITDA CAGR (5Y)12.60%

EBITDA Interim CAGR (5Y)-16.81%

ROE (Last FY)12.35%

Net Interest Coverage (Annual)3.08x

EPS Basic Excl Extra (Annual)$0.33

P/FCF (TTM)11.86x

Receivables Turnover (TTM)4.30x

EV / Free Cash Flow (TTM)14.28x

Total Debt / Equity (Quarterly)1.13x

EPS Incl Extra (TTM)$0.78

Receivables Turnover (Annual)4.44x

ROI (TTM)11.21%

P/S Ratio (TTM)1.92x

Pretax Margin (5Y Avg)-15.60%

Revenue / Share (Annual)$8.24

Tangible BV / Share (Annual)$-9.45

Forward P/E15.59x

Free OCF CAGR (5Y)1.27%

Price vs S&P 500 (52W)77.78%

P/E Ratio (TTM)20.54x

Year-to-Date Return78.76%

5-Day Price Return-1.70%

EPS Normalized (Annual)$0.33

ROA (5Y Avg)-6.18%

Net Profit Margin (Annual)4.00%

Month-to-Date Return-2.42%

Cash Flow / Share (TTM)$-1.35

EBITD / Share (Annual)$0.86

Operating Margin (Annual)9.44%

LT Debt / Equity (Annual)1.52x

P/CF (TTM)11.55x

ROI (5Y Avg)-9.77%

P/E Excl Extra (TTM)20.54x

LT Debt / Equity (Quarterly)1.01x

EPS Basic Excl Extra (TTM)$0.78

P/B Ratio (Annual)3.34x

Inventory Turnover (TTM)2.07x

Pretax Margin (TTM)6.64%

Book Value / Share (Annual)$2.22

Price vs S&P 500 (13W)7.60%

Net Margin Growth (5Y)-4.78%

Beta0.66x

P/FCF (Annual)15.51x

Revenue / Share (TTM)$8.21

ROE (TTM)28.39%

52-Week Low$6.47

vGradeB

gGradeC

mGradeA

vgmGradeB

BVS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	$0.22	$0.22	+0.92%(+$0.00)
Q1 2026	May 6, 2026	$0.07	$0.15	+120.59%(+$0.08)
Q4 2025	Mar 5, 2026	$0.22	$0.24	+10.77%(+$0.02)
Q3 2025	Nov 4, 2025	$0.12	$0.15	+30.43%(+$0.03)
Q2 2025	Aug 6, 2025	$0.20	$0.21	+6.78%(+$0.01)

BVS Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.11

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Bioventus Inc. Class A Common Stock

Bioventus Inc. is a medical technology company that develops clinically differentiated treatments enhancing natural healing processes across the orthopedic continuum. Its product portfolio serves multiple orthopedic specialties—including sports medicine, joint reconstruction, trauma, and spine surgery—organized into three verticals: Pain Treatments, Surgical Solutions, and Restorative Therapies. The company generates key revenue in the United States with growing international market presence.

BVS Next Earnings Report

Report dateNov 3, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate$0.16

Revenue estimate$149.52M

Also reporting on Nov 3, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

ENOVEnovis CorporationOrthopedic & Prosthetic Devices
CDRECadre Holdings, Inc.Orthopedic & Prosthetic Devices
STAAStaar Surgical CoOphthalmic Goods
CBLLCeriBell, Inc. Common StockElectromedical Equipment
KODKEASTMAN KODAK COMPANYPhotographic Equipment & Supplies
INMDInMode Ltd. Ordinary SharesElectromedical Equipment
TRNSTranscat IncInstruments for Measuring
FEIMFrequency Electronics, Inc.Instruments for Measuring

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$6.47

High$15.89